Assessment of the Contribution to Drug Impaired Driving from Emerging and Undertested Drugs

Content Advisory

Please be aware that this content contains descriptions of violence that may be distressing to some viewers.
NCJ Number
307336
Date Published
2023
Length
27 pages
Annotation

This document reports on research that aimed to better characterize the contribution to drug-impaired driving in the U.S. associated with compounds that are not included as part of the standardized scope of testing set forth by the NSC-ADID recommendations.

Abstract

This research report describes a project that aimed to comprehensively test blood samples collected and submitted for analysis to a reference laboratory for both Tier I and Tier II drugs and other emergent substances, including NPS in suspected Driving Under the Influence of Drugs (DUID) cases. The report presents the following information: the authors’ research questions; research design, methods, analytical and data analysis techniques, including sample acquisition and assessment; participants and other collaborating organizations; changes in approach to research and reasons for change; and outcomes for the five objectives. The authors’ objectives were: sample acquisition and analysis; method development and validation for identified analytes of interest; Drug Recognition Expert (DRE) evaluations; four-year assessment of DUID drug concentrations; and dissemination of research findings.

Grant Number(s)
2020-DQ-BX-0009
Agencies
NIJ-Sponsored
Publication Type
Program/Project Evaluation
Date Published: January 1, 2023